Vital Therapies Inc (VTL) SEC Filing 8-K Material Event for the period ending Thursday, October 25, 2018

Vital Therapies Inc

CIK: 1280776 Ticker: VTL

View differences made from one to another to evaluate Vital Therapies Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Vital Therapies Inc.


Assess how Vital Therapies Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Vital Therapies Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: VTL
CIK: 1280776
Form Type: 8-K Corporate News
Accession Number: 0001280776-18-000100
Submitted to the SEC: Fri Oct 26 2018 4:56:07 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: